Clinical Trials Browser

Phase 2/3 × Leukemia × Decitabine × Clear all

NCT03799224 2019-05-29

Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia